Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Ellul

Showing results (121-130 of 167) with videos related to

Pageof 17
Sort By:
Therapeutic Advances in Gastroenterology|September 2, 2025
The CROCO (CROhn's Disease COhort Study) - study design and protocolJoana Revés, Anthony Buisson, Johan Burisch, et al.
Journal of Crohn'S & Colitis|June 23, 2023
ECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel DiseaseHannah Gordon, Johan Burisch, Pierre Ellul, et al.
Lupus|February 5, 2024
Juvenile neuropsychiatric systemic lupus erythematosus: A specific clinical phenotype and proposal of a probability scoreMathilde Labouret, Vincent Trebossen, Alexandra Ntorkou, et al.
Therapeutic Advances in Gastroenterology|October 25, 2024
Bowel cleansing quality evaluation in colon capsule endoscopy: what is the reference standard?Benedicte Schelde-Olesen, Anastasios Koulaouzidis, Ulrik Deding, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 19, 2016
Discontinuation of Infliximab in Patients With Ulcerative Colitis Is Associated With Increased Risk of Relapse: A Multinational Retrospective Cohort StudyGionata Fiorino, Pablo Navarro Cortes, Pierre Ellul, et al.
Journal of Crohn'S & Colitis|October 12, 2019
Interstitial and Granulomatous Lung Disease in Inflammatory Bowel Disease PatientsElena Eliadou, Joana Moleiro, Davide Giuseppe Ribaldone, et al.
The American Journal of Gastroenterology|February 2, 2024
Rates of Adverse Events in Patients With Ulcerative Colitis Undergoing Colectomy During Treatment With Tofacitinib vs Biologics: A Multicenter Observational StudyGabriele Dragoni, Tommaso Innocenti, Aurelién Amiot, et al.
Journal of Crohn'S & Colitis|December 18, 2022
ECCO Guidelines on Inflammatory Bowel Disease and MalignanciesHannah Gordon, Livia Biancone, Gionata Fiorino, et al.
Journal of Crohn'S & Colitis|November 2, 2022
Post-inflammatory Polyp Burden as a Prognostic Marker of Disease-outcome in Patients with Inflammatory Bowel DiseasePierre Ellul, John Schembri, Andrea Vella Baldacchino, et al.
European Journal of Clinical Investigation|July 9, 2024
An international multicentre study of SwiTching from Intravenous to subcutaneous inflixiMab and vEdolizumab in inflammatory bowel diseases: The TIME studyFerdinando D'Amico, Luca Massimino, Giulia Palmieri, et al.
Pageof 17

Showing results (121-130 of 167) with videos related to

Sort By:
Pageof 17
Therapeutic Advances in Gastroenterology|September 2, 2025
The CROCO (CROhn's Disease COhort Study) - study design and protocolJoana Revés, Anthony Buisson, Johan Burisch, et al.
Journal of Crohn'S & Colitis|June 23, 2023
ECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel DiseaseHannah Gordon, Johan Burisch, Pierre Ellul, et al.
Lupus|February 5, 2024
Juvenile neuropsychiatric systemic lupus erythematosus: A specific clinical phenotype and proposal of a probability scoreMathilde Labouret, Vincent Trebossen, Alexandra Ntorkou, et al.
Therapeutic Advances in Gastroenterology|October 25, 2024
Bowel cleansing quality evaluation in colon capsule endoscopy: what is the reference standard?Benedicte Schelde-Olesen, Anastasios Koulaouzidis, Ulrik Deding, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 19, 2016
Discontinuation of Infliximab in Patients With Ulcerative Colitis Is Associated With Increased Risk of Relapse: A Multinational Retrospective Cohort StudyGionata Fiorino, Pablo Navarro Cortes, Pierre Ellul, et al.
Journal of Crohn'S & Colitis|October 12, 2019
Interstitial and Granulomatous Lung Disease in Inflammatory Bowel Disease PatientsElena Eliadou, Joana Moleiro, Davide Giuseppe Ribaldone, et al.
The American Journal of Gastroenterology|February 2, 2024
Rates of Adverse Events in Patients With Ulcerative Colitis Undergoing Colectomy During Treatment With Tofacitinib vs Biologics: A Multicenter Observational StudyGabriele Dragoni, Tommaso Innocenti, Aurelién Amiot, et al.
Journal of Crohn'S & Colitis|December 18, 2022
ECCO Guidelines on Inflammatory Bowel Disease and MalignanciesHannah Gordon, Livia Biancone, Gionata Fiorino, et al.
Journal of Crohn'S & Colitis|November 2, 2022
Post-inflammatory Polyp Burden as a Prognostic Marker of Disease-outcome in Patients with Inflammatory Bowel DiseasePierre Ellul, John Schembri, Andrea Vella Baldacchino, et al.
European Journal of Clinical Investigation|July 9, 2024
An international multicentre study of SwiTching from Intravenous to subcutaneous inflixiMab and vEdolizumab in inflammatory bowel diseases: The TIME studyFerdinando D'Amico, Luca Massimino, Giulia Palmieri, et al.
Pageof 17